Medical Advertisement Ministry of Health Appl. No. ZZ46220 – valid upto 11.06.2018
Synlab Announcement Group Chief and Chairman
Labco and synlab - Senior Appointments, 09/2015
Labco and synlab - Senior Appointments
The European clinical diagnostics businesses, Labco and synlab, today announce that Dr. Bartl Wimmer will be appointedas Group Chief Executive and Philippe Charrier as Executive Chairman of the combined group
This announcement follows the acquisitions of Labco and synlab by European private equity firm Cinven in May and June respectively. These positions will be effective once Cinven's acquisitions of both Labco and synlab have completed, which is expected to be in September 2015.
Dr. Bartl Wimmer is currently Chief Executive Officer of synlab. He was the co-founder of the synlab business in 1998 and has acted as Managing Director since its establishment. Since January 2010, he has held the position of CEO with responsibility for the successful acquisition and integration of numerous medical diagnostics laboratories across Germany and Europe.
Philippe Charrier is currently Chief Executive Officer of Labco. He joined the Board of Labco in 2011 and was previously CEO of Oenobiol, the personal beauty care product firm. During 1999 to 2006, he was CEO of P&G France. During his tenure as CEO, Philippe Charrier has overseen significant growth and expansion at Labco building it into the pre-eminent operator of clinical laboratories in Western Europe.
Click for pdf
according to ISO 15189
SAT - THU 9:00 AM to 9:00 PM | FRIDAY : 9:00 AM to 1:00 PM